Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Harsha Rao MD, PhD

Harsha Rao MD, PhD

Consultant, Narayana Nethralaya, Bangalore, India; Faculty, University Eye Clinic Maastricht, University Medical Center, Maastricht, The Netherlands
Dr. Rao is a consultant for Santen and Allergan. He has also received research support from Carl-Zeiss Meditec.

Dr. Harsha Rao is currently working as a consultant in the Department of Glaucoma at Narayana Nethralaya, Bengaluru. He is also on faculty at the University Eye Clinic Maastricht, University Medical Center, Maastricht, the Netherlands. He completed his basic medical education and Post-Graduation in Ophthalmology from Bangalore Medical College, Bangalore. He subsequently completed his long term fellowship in Glaucoma at L V Prasad Eye Institute, Hyderabad followed by another long term fellowship in Glaucoma at the University of California, San Diego. He worked as a Glaucoma consultant at L V Prasad Eye Institute, Hyderabad from 2007 to 2015 before joining Narayana Nethralaya. He had also held the positions of Adjunct Assistant Professor of Ophthalmology at the School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, New York between October 2010 and April 2015, and the School of Medicine, Case Western Reserve University, Cleveland, Ohio between July 2011 and April 2015. He was a member of the Associate Advisory Board of World Glaucoma Association from 2011 to 2019. He completed his PhD from Maastricht University, Netherlands in 2018.

He has published over 150 papers in peer-reviewed scientific journals (with a H-index of 33) and has been an invited speaker at multiple national and international conferences. He is on the editorial board of multiple journals and is a reviewer for most of the high impact journals in Ophthalmology. He is a council member of the Asia-Pacific Ocular Imaging Society.